Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction, STabilization, Adherence, and Retention Trial (ISTART) - A Randomized, Non-inferiority, Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments

NCT01908842 is registered in ClinicalTrials.gov with Orexo AB as lead sponsor.

NCT NCT01908842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01908842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction, STabilization, Adherence, and Retention Trial (ISTART) - A Randomized, Non-inferiority, Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments
Lead sponsor
Orexo AB
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2013
Completion date
April 30, 2014
Enrollment
759 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence, on agonist therapy